ClinicalTrials.Veeva

Menu

Udall Project 1 Aim 4

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Enrolling

Conditions

Deep Brain Stimulation
Parkinsons Disease

Study type

Observational

Funder types

Other

Identifiers

NCT05568199
STUDY00007781

Details and patient eligibility

About

By defining the strength and direction of connectivity patterns at rest and during movement across the basal ganglia-thalamocortical (BGTC) network we will characterize the role of individual circuits in motor performance and cognitive function, paving the way for future development of optimization algorithms for DBS that take advantage of this understanding.

Enrollment

100 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Implanted with a DBS system
  • Existing 7T imagery (either done as standard-of-care or done as part of Noam Harel's study, IRB #1210M22183)
  • Diagnosed with idiopathic Parkinson's Disease
  • Minimum age 21 years

Exclusion criteria

  • Other significant neurological disorder, as determined by PI
  • Diagnosis of dementia
  • Pregnant

Trial design

100 participants in 3 patient groups

Group 1
Description:
Patients will make one visit to the M Health Clinical Research Unit (CRU) after overnight withdrawal of PD medications (still on-DBS) and undergo motor and cognitive assessments in the following three conditions: 1. clinically-optimized stimulation 2. model-based stimulation directed towards motor subregions of STN and GPi 3. model-based stimulation directed towards associative/limbic subregions of STN/GPi Randomized to start with condition1 assessment
Group 2
Description:
Patients will make one visit to the M Health Clinical Research Unit (CRU) after overnight withdrawal of PD medications (still on-DBS) and undergo motor and cognitive assessments in the following three conditions: 1. clinically-optimized stimulation 2. model-based stimulation directed towards motor subregions of STN and GPi 3. model-based stimulation directed towards associative/limbic subregions of STN/GPi Randomized to start with condition 2 assessment
Group 3
Description:
Patients will make one visit to the M Health Clinical Research Unit (CRU) after overnight withdrawal of PD medications (still on-DBS) and undergo motor and cognitive assessments in the following three conditions: 1. clinically-optimized stimulation 2. model-based stimulation directed towards motor subregions of STN and GPi 3. model-based stimulation directed towards associative/limbic subregions of STN/GPi Randomized to start with condition 3 assessment

Trial contacts and locations

1

Loading...

Central trial contact

Niecy Beltz

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems